Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/10/2012CN102719389A Capsule deficiency type Streptococcus equi subsp. zooepidemicus attenuated vaccine strain and preparation method thereof
10/10/2012CN102718867A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/10/2012CN102718865A Humanized anti-EV71 virus neutralizing antibody EV71FabL11, preparation method and application thereof
10/10/2012CN102718864A Human anti-EV71 (enterovirus 71) neutralizing antibody EV71FabK7 and preparation method and application thereof
10/10/2012CN102718863A H5 subtype specific binding protein capable of diagnosing and monitoring H5 avian influenza
10/10/2012CN102718855A Anti-Pf 332-DBL sectional monoclonal antibody capable of inhibiting invasion of plasmodium falciparum
10/10/2012CN102716499A Streptococcus iniae trivalent DNA vaccine and construction method thereof
10/10/2012CN102716485A Dual hyper-immune egg yolk antibody injection for duck virus hepatitis and duck plague and preparation method thereof
10/10/2012CN102716484A Duck virus hepatitis yolk antibody freeze-dried powder and preparation method thereof
10/10/2012CN102716483A Duck plague yolk antibody freeze-dried powder and preparation method thereof
10/10/2012CN102716482A Highly pathogenic porcine reproductive and respiratory syndrome live vaccine diluted solution
10/10/2012CN102716481A Immunoadjuvant of oral vaccine for tilapia and use thereof
10/10/2012CN102716480A 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition
10/10/2012CN102716479A Pig breeding and respiratory syndrome NVDC-JXA1 strain-porcine parvovirus disease duplex inactivated vaccine and preparation method and application thereof
10/10/2012CN102716478A Combined Newcastle disease and infectious bronchitis inactivated vaccine and method for preparing same
10/10/2012CN102716477A Stability of protein in aqueous solution
10/10/2012CN102716476A Cell inactivated vaccine, egg yolk antibody injection, and preparation method of cell inactivated vaccine
10/10/2012CN102716475A Preparation method of cow mammitis vaccines
10/10/2012CN102716474A Application of protein Rh054_01780 to rickettsia heilongjiangensis-resistant immune protection
10/10/2012CN102716473A Active immunoregulation method for fused prolactin proteins of goose eggs
10/10/2012CN102716472A Tumor vaccine and synthetic method thereof
10/10/2012CN102228687B Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine
10/10/2012CN102204933B Preparation method of biological anti-tumor product
10/10/2012CN102166362B Porcine reproductive and respiratory syndrome live vaccine heat-resistant freeze-drying protective agent and preparation method thereof
10/10/2012CN102153654B Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide
10/10/2012CN102145179B Application of IL-1ra-Fcepsilon fusion gene and coded protein thereof to treatment on allergic rhinitis
10/10/2012CN101926994B Turtle shell immunoadjuvant and influenza vaccine containing the same
10/10/2012CN101914501B Foot and mouth disease virus-like particle, preparation method and application thereof
10/10/2012CN101906403B Enterovirus and application thereof
10/10/2012CN101880675B High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application
10/10/2012CN101857636B Anti-interferon-alpha antibodies
10/10/2012CN101845084B Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen
10/10/2012CN101636179B Antagonists of pcsk9
10/10/2012CN101610786B Prevention and treatment of sub-clinical pcvd
10/10/2012CN101524536B Japanese encephalitis vaccine prepared by human embryonic lung fibroblasts and preparation method thereof
10/10/2012CN101444624B Medicine for cancer therapy
10/10/2012CN101415819B Anti-IL-6 antibodies, compositions, methods and uses
10/10/2012CN101389351B Human anti-il-23 antibodies, compositions, methods and uses
10/10/2012CN101384699B Method of producing rough strains of bacteria and uses thereof
10/10/2012CN101309704B Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101258165B Humanised antibodies specific for nogo-a and pharmaceutical uses thereof
10/10/2012CN101193912B Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
10/10/2012CN101163718B Reagents that bind ccx-ckr2
10/10/2012CN101146554B Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/10/2012CN101128215B Immunogenic composition for use in vaccination against staphylococcei
10/10/2012CN101083907B Compositions and methods for topical diagnostic and therapeutic transport
10/10/2012CN101057975B Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/10/2012CN101052414B Immunogenic HBc chimer particles having enhanced stability
10/10/2012CN101010002B Cancer selective auxotrophs
10/09/2012US8283518 Administration of transposon-based vectors to reproductive organs
10/09/2012US8283458 VMP-like sequences of pathogenic Borrelia species and strains
10/09/2012US8283452 Assay for the separation and quantification of hemagglutinin antigens
10/09/2012US8283448 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
10/09/2012US8283444 Non-viral delivery of compounds to mitochondria
10/09/2012US8283440 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
10/09/2012US8283315 Inhibition of tumour growth
10/09/2012US8283161 Tumour cell lines and uses thereof
10/09/2012US8282943 Therapeutic composition for use in the prevention and treatment of bone metastases
10/09/2012US8282942 Toxoplasma gondii vaccines and uses thereof
10/09/2012US8282941 Immunizing compositions and methods of use
10/09/2012US8282940 Adjuvant viral particle
10/09/2012US8282939 Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies
10/09/2012US8282938 Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain
10/09/2012US8282937 To produce vaccines to prophylactically and therapeutically treat influenza
10/09/2012US8282936 Human papillomavirus vaccine for oral administration
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012US8282934 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
10/09/2012US8282933 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease
10/09/2012US8282932 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
10/09/2012US8282931 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
10/09/2012US8282930 Molecular delivery vehicle
10/09/2012US8282929 Methods of treating a disease with anti-C5 alpha antibodies
10/09/2012US8282928 Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/09/2012US8282927 Immunoglobulin fraction and process therefor
10/09/2012US8282926 CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5
10/09/2012US8282925 Method for treating rheumatoid arthritis using anti-S100A9 antibody
10/09/2012US8282923 Antibodies which bind and inhibit blood factor VIII
10/09/2012US8282922 Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibody
10/09/2012US8282920 Phage therapy against Pseudomonas aeruginosa
10/09/2012US8282915 Transgenic algae for delivering antigens to an animal
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2480389C Modified saccharides having improved stability in water
10/09/2012CA2476901C Anti-ccr5 antibody
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2323751C Diagnostics and vaccines for mycobacterial infections of animals and humans
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135854A2 Antibodies to cytosolic peptides
10/04/2012WO2012135812A2 Treatment for dermatological pathologies
10/04/2012WO2012135740A2 Cd37-binding molecules and immunoconjugates thereof
10/04/2012WO2012135695A2 Modulation of cellular migration
10/04/2012WO2012135675A2 Methods for increasing efficacy of folr1 cancer therapy
10/04/2012WO2012135671A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135624A1 Treatment of colon cancer using complement inhibitors
10/04/2012WO2012135616A1 Vaccination against advanced glycation end-products
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 1823